- Hoth Therapeutics, Inc. (HOTH) - Yahoo Finance
Hoth Therapeutics Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated HT-KIT, Advancing HT-001 Phase 2, and New GDNF Metabolic Program
- HT Media Limited (HTMEDIA. NS) - Yahoo Finance
Find the latest HT Media Limited (HTMEDIA NS) stock quote, history, news and other vital information to help you with your stock trading and investing
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a . . .
HT-4253 was generally well tolerated across all dose levels, with no serious adverse events reported A comprehensive Clinical Study Report (CSR) is anticipated in Q4 2025
- Huobi Token USD Price (HT-USD) - Yahoo Finance
Find the live Huobi Token USD (HT-USD) price, history, news and other vital information to help with your cryptocurrency trading and investing
- Hoth Therapeutics Issues Shareholder Update: HT-001, HT-KIT, Expanded . . .
Hoth Therapeutics, Inc (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced a comprehensive shareholder update, underscoring momentum across its lead clinical programs and
- Hoth Therapeutics Soars 215% on Breakthrough Cancer Treatment Success
Their Phase 2a clinical trial of Hoth's topical gel HT-001 has shown 100% success in combating skin toxicities caused by Epidermal Growth Factor Receptor Inhibitors (EGFRi) in cancer patients
- EXCLUSIVE: Hoth Therapeutics Antisense Therapy Demonstrates Efficacy . . .
Hoth Therapeutics Inc (NASDAQ:HOTH) on Tuesday announced combined findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT
- Advent Technologies Powers the Future of Flight with Next-Generation . . .
“By partnering with Advent early in our design cycle, we were able to integrate HT-PEM technology and fully leverage its performance and cooling advantages ”
|